Back to companies

Genscript Biotech Corp: Patents

Select Item

View up-to-date information on Genscript Biotech Corp patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
AU2020200151C1 Grant Chimeric antigen receptors based on single-domain antibodies and methods of use thereof A61K2039/5156; A61K35/17; A61K39/001117; A61P35/00; A61P35/02; A61P7/00; C07K14/435; C07K14/7051; C07K14/70517; C07K14/70521; C07K14/70575; C07K14/70578; C07K14/70596; C07K16/2803; C07K16/2878; C07K16/2887; C07K16/2896; C07K16/30; C07K16/3061; C07K19/00; C07K2317/22; C07K2317/24; C07K2317/31; C07K2317/35; C07K2317/565; C07K2317/569; C07K2317/622; C07K2317/92; C07K2319/02; C07K2319/03; C07K2319/21; C07K2319/30; C07K2319/33; C07K2319/74; C12N15/62; C12N15/63; C12N2510/00; C12N5/0636; C12N5/10 September 08, 2022
IL294683A Application Chimeric antigen receptors based on single-domain antibodies and methods of use thereof A61K2039/5156; A61K35/17; A61K39/001117; A61P35/00; A61P35/02; A61P7/00; C07K14/435; C07K14/7051; C07K14/70517; C07K14/70521; C07K14/70575; C07K14/70578; C07K14/70596; C07K16/2803; C07K16/2878; C07K16/2887; C07K16/2896; C07K16/30; C07K16/3061; C07K19/00; C07K2317/22; C07K2317/24; C07K2317/31; C07K2317/35; C07K2317/565; C07K2317/569; C07K2317/622; C07K2317/92; C07K2319/02; C07K2319/03; C07K2319/21; C07K2319/30; C07K2319/33; C07K2319/74; C12N15/62; C12N15/63; C12N2510/00; C12N5/0636; C12N5/10 September 01, 2022
IL257297B Grant Chimeric antigen receptors based on single-domain antibodies and methods of use thereof A61K2039/5156; A61K35/17; A61K39/001117; A61P35/00; A61P35/02; A61P7/00; C07K14/435; C07K14/7051; C07K14/70517; C07K14/70521; C07K14/70575; C07K14/70578; C07K14/70596; C07K16/2803; C07K16/2878; C07K16/2887; C07K16/2896; C07K16/30; C07K16/3061; C07K19/00; C07K2317/22; C07K2317/24; C07K2317/31; C07K2317/35; C07K2317/565; C07K2317/569; C07K2317/622; C07K2317/92; C07K2319/02; C07K2319/03; C07K2319/21; C07K2319/30; C07K2319/33; C07K2319/74; C12N15/62; C12N15/63; C12N2510/00; C12N5/0636; C12N5/10 August 01, 2022
US20220220454A1 Application THERMOSTABLE GLUCOSE OXIDASE C12N15/82; C12N9/0006; C12R2001/66; C12Y101/03004 July 14, 2022
AU2022204180A1 Application Chimeric antigen receptors based on single-domain antibodies and methods of use thereof A61K2039/5156; A61K35/17; A61K39/001117; A61P35/00; A61P35/02; A61P7/00; C07K14/435; C07K14/7051; C07K14/70517; C07K14/70521; C07K14/70575; C07K14/70578; C07K14/70596; C07K16/2803; C07K16/2878; C07K16/2887; C07K16/2896; C07K16/30; C07K16/3061; C07K19/00; C07K2317/22; C07K2317/24; C07K2317/31; C07K2317/35; C07K2317/565; C07K2317/569; C07K2317/622; C07K2317/92; C07K2319/02; C07K2319/03; C07K2319/21; C07K2319/30; C07K2319/33; C07K2319/74; C12N15/62; C12N15/63; C12N2510/00; C12N5/0636; C12N5/10 July 07, 2022
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Contact Us

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Contact Us
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code